cost effectiveness of ‘on demand’ hiv pre-exposure prophylaxis for non-injection drug-using men who have sex with men in canada
Clicks: 246
ID: 227494
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
246 views
50 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #13 of 94 articles by views in zdravstveno varstvo
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Recent trials report the efficacy of continuous tenofovir-based pre-exposure prophylaxis (PrEP) for prevention of HIV infection. The cost effectiveness of ‘on demand’ PrEP for non-injection drug-using men who have sex with men at high risk of HIV acquisition has not been evaluated.
| Reference Key |
ouellet2015canadiancost
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Estelle Ouellet;Madeleine Durand;Jason R Guertin;Jacques LeLorier;Cécile L Tremblay |
| Journal | zdravstveno varstvo |
| Year | 2015 |
| DOI |
10.1155/2015/964512
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.